医学
内科学
心脏病学
经皮冠状动脉介入治疗
冠状动脉疾病
狭窄
临床终点
心绞痛
传统PCI
入射(几何)
心肌梗塞
随机对照试验
光学
物理
作者
Byoung Geol Choi,Sung Hun Park,Seung‐Woon Rha,Jihun Ahn,Jah Yeon Choi,Jae Kyeong Byun,Hu Li,Ahmed Mashaly,Min Suk Shim,Jun Hyuk Kang,Woohyeun Kim,Jah Yeon Choi,Eun Jin Park,Sunki Lee,Jin Oh Na,Cheol Ung Choi,Hong Euy Lim,Eung Ju Kim,Chang Gyu Park,Hong Seog Seo,Dong Joo Oh
标识
DOI:10.1016/j.ijcard.2017.03.081
摘要
Coronary artery spasm (CAS) and significant coronary stenosis are known to be major causes of myocardial ischemia. However, their association and the impact of insignificant coronary stenosis (ICS) on long-term clinical outcomes of CAS patients are largely unknown.A total of 2797 patients without significant coronary artery disease (CAD) who underwent the acetylcholine (ACH) provocation test between November 2004 and October 2010 were enrolled. Significant CAS was defined as having ≥70% of temporary narrowing by ACH test and ICS as having <70% of fixed stenosis on angiography. Patients were divided into two groups: ICS group (n=764) and non-ICS group (n=845). To adjust potential confounders, a propensity score matching (PSM) analysis was performed using the logistic regression model. Primary endpoint was the composite of total death, myocardial infraction (MI), de novo percutaneous coronary intervention (PCI), and cerebrovascular accidents (CVA). Secondary endpoint was the incidence of recurrent angina requiring repeat coronary angiography (CAG) at 3years.After PSM analysis, two well-balanced groups (548 pairs, total=1096) were generated. The baseline clinical characteristics were similar between the two groups. During the ACH test, compared with the non-ICS group, the ICS group had smaller spastic narrowing diameter (0.69±0.35 vs. 0.73±0.37, P=0.039) and incidence of ST-segment depression (4.0% vs. 0.9%, P=0.001). The incidence of primary and secondary endpoints was similar between the two groups up to 3years.Although, the ICS group was expected to have more adverse long-term clinical outcomes, it was not associated with the increased incidence of major adverse clinical outcomes compared with the non-ICS group up to 3years. Longer term follow-up studies are needed.
科研通智能强力驱动
Strongly Powered by AbleSci AI